Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies

Aydin Nazmi, Cesar G Victora, Aydin Nazmi, Cesar G Victora

Abstract

Background: Socioeconomic and racial/ethnic factors strongly influence cardiovascular disease outcomes and risk factors. C-reactive protein (CRP), a non-specific marker of inflammation, is associated with cardiovascular risk, and knowledge about its distribution in the population may help direct preventive efforts. A systematic review was undertaken to critically assess CRP levels according to socioeconomic and racial/ethnic factors.

Methods: Medline was searched through December 2006 for population-based studies examining CRP levels among adults with respect to indicators of socioeconomic position (SEP) and/or race/ethnicity. Bibliographies from located studies were scanned and 26 experts in the field were contacted for unpublished work.

Results: Thirty-two relevant articles were located. Cross-sectional (n = 20) and cohort studies (n = 11) were included, as was the control group of one trial. CRP levels were examined with respect to SEP and race/ethnicity in 25 and 15 analyses, respectively. Of 20 studies that were unadjusted or adjusted for demographic variables, 19 found inverse associations between CRP levels and SEP. Of 15 similar studies, 14 found differences between racial/ethnic groups such that whites had the lowest while blacks, Hispanics and South Asians had the highest CRP levels. Most studies also included adjustment for potential mediating variables in the causal chain between SEP or race/ethnicity and CRP. Most of these studies showed attenuated but still significant associations.

Conclusion: Increasing poverty and non-white race was associated with elevated CRP levels among adults. Most analyses in the literature are underestimating the true effects of racial/ethnic and socioeconomic factors due to adjustment for mediating factors.

Figures

Figure 1
Figure 1
Conceptual model for the associations between race/ethnicity, socioeconomic position and C-reactive protein level.
Figure 2
Figure 2
Number of studies associated with process of study selection (according to QUOROM guidelines).

References

    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global Burden of Disease and Risk Factors. NY , Oxford University Press; 2006.
    1. WHO WHO Global Strategy on Diet, Physical Activity and Health. Cardiovascular disease: prevention and control
    1. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T. Trends and Disparities in Coronary Heart Disease, Stroke, and Other Cardiovascular Diseases in the United States : Findings of the National Conference on Cardiovascular Disease Prevention. Circulation. 2000;102:3137–3147.
    1. Cooper RS. Social inequality, ethnicity and cardiovascular disease. Int J Epidemiol. 2001;30:S48–52.
    1. Dalstra JAA, Kunst AE, Borrell C, Breeze E, Cambois E, Costa G, Geurts JJM, Lahelma E, Van Oyen H, Rasmussen NK, Regidor E, Spadea T, Mackenbach JP. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol. 2005;34:316–326. doi: 10.1093/ije/dyh386.
    1. Mackenbach JP, Cavelaars AEJM, Kunst AE, Groenhof F. Socioeconomic inequalities in cardiovascular disease mortality. An international study. Eur Heart J. 2000;21:1141–1151. doi: 10.1053/euhj.1999.1990.
    1. Winkleby MA, Kraemer HC, Ahn DK, Varady AN. Ethnic and Socioeconomic Differences in Cardiovascular Disease Risk Factors: Findings for Women From the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA. 1998;280:356–362. doi: 10.1001/jama.280.4.356.
    1. Yarnell J, Yu S, McCrum E, Arveiler D, Hass B, Dallongeville J, Montaye M, Amouyel P, Ferrieres J, Ruidavets JB, Evans A, Bingham A, Ducimetiere P, for the P. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol. 2005;34:268–275. doi: 10.1093/ije/dyh267.
    1. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Lancet. 2000;356:279. doi: 10.1016/S0140-6736(00)02502-2.
    1. Sundquist J, Winkleby MA, Pudaric S. Cardiovascular Disease Risk Factors Among Older Black, Mexican-American, and White Women and Men: An Analysis of NHANES III, 1988-1994. J Am Geriatr Soc. 2001;49:109–116. doi: 10.1046/j.1532-5415.2001.49030.x.
    1. Ross R. Mechanisms of Disease: Atherosclerosis - An Inflammatory Disease. N Engl J Med. 1999;340:115–126. doi: 10.1056/NEJM199901143400207.
    1. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805–1812. doi: 10.1172/JCI200318921.
    1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men. N Engl J Med. 1997;336:973–979. doi: 10.1056/NEJM199704033361401.
    1. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, Hutchinson WL, Pepys MB. C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men. Results From the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99:237–242.
    1. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eda G, Rumley A, Lowe GDO, Pepys MB, Gudnason V. C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease. N Engl J Med. 2004;350:1387–1397. doi: 10.1056/NEJMoa032804.
    1. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women. Circulation. 1998;98:731–733.
    1. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108:2317–2322. doi: 10.1161/01.CIR.0000097109.90783.FC.
    1. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GDO, O'Reilly DSJ, Packard CJ, Sattar N. C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002;51:1596–1600. doi: 10.2337/diabetes.51.5.1596.
    1. Hu FB, Meigs JB, Li TY, Rifai N, Manson JAE. Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women. Diabetes. 2004;53:693–700. doi: 10.2337/diabetes.53.3.693.
    1. Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M, Koenig W. C-Reactive Protein as a Predictor for Incident Diabetes Mellitus Among Middle-aged Men: Results From the MONICA Augsburg Cohort Study, 1984-1998. Arch Intern Med. 2003;163:93–99. doi: 10.1001/archinte.163.1.93.
    1. Ridker PM, Glynn RJ, Hennekens CH. C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction. Circulation. 1998;97:2007–2011.
    1. Blake GJ, Rifai N, Buring JE, Ridker PM. Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events. Circulation. 2003;108:2993–2999. doi: 10.1161/.
    1. Pasceri V, Willerson JT, Yeh ETH. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells. Circulation. 2000;102:2165–2168.
    1. Verma S, Szmitko PE, Yeh ETH. C-Reactive Protein: Structure Affects Function. Circulation. 2004;109:1914–1917. doi: 10.1161/01.CIR.0000127085.32999.64.
    1. Pepys MB. CRP or not CRP? That Is the Question. Arterioscler Thromb Vasc Biol. 2005;25:1091–1094. doi: 10.1161/01.ATV.0000169644.88847.28.
    1. Lawlor DA, Davey Smith G, Rumley A, Lowe GD, Ebrahim S. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study. Thromb Haemost. 2005;93:955–963.
    1. Davey Smith G, Lawlor DA, Harbord R, Timpson N, Rumley A, Lowe GDO, Day INM, Ebrahim S. Association of C-Reactive Protein With Blood Pressure and Hypertension: Life Course Confounding and Mendelian Randomization Tests of Causality. Arterioscler Thromb Vasc Biol. 2005;25:1051–1056. doi: 10.1161/01.ATV.0000160351.95181.d0.
    1. Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day INM, Palmer LJ, Hattersley AT, Ebrahim S, Lowe DOG, Rumley A, Davey-Smith G. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet. 2005;366:1954–1959. doi: 10.1016/S0140-6736(05)67786-0.
    1. Casas JP, Shah T, Cooper J, Hawe E, McMahon AD, Gaffney D, Packard CJ, O'Reilly DS, Juhan-Vague I, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Kooistra T, Stephens JW, Hurel SJ, Livingstone S, Colhoun HM, Miller GJ, Bautista LE, Meade T, Sattar N, Humphries SE, Hingorani AD. Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol. 2006;35:922–931. doi: 10.1093/ije/dyl041.
    1. Victora CG, Huttly SR, Fuchs SC, Olinto MTA. The Role of Conceptual Frameworks in Epidemiological Analysis: A Hierarchical Approach. Int J Epidemiol. 1997;26:224–227. doi: 10.1093/ije/26.1.224.
    1. Oakes M, Kaufman J. Methods for social epidemiology. San Francisco , Jossey Bass; 2005.
    1. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, for the QUOROM Group Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet. 1999;354:1896–1900. doi: 10.1016/S0140-6736(99)04149-5.
    1. Abramson JL, Weintraub WS, Vaccarino V. Association Between Pulse Pressure and C-Reactive Protein Among Apparently Healthy US Adults. Hypertension. 2002;39:197–202. doi: 10.1161/hy0202.104270.
    1. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312:1061–1065.
    1. Danner M, Kasl SV, Abramson JL, Vaccarino V. Association Between Depression and Elevated C-Reactive Protein. Psychosom Med. 2003;65:347–356. doi: 10.1097/01.PSY.0000041542.29808.01.
    1. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology. 2002;13:561–568. doi: 10.1097/00001648-200209000-00012.
    1. Ford ES, Giles WH. Serum C-Reactive Protein and Self-Reported Stroke : Findings From the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol. 2000;20:1052–1056.
    1. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord. 2001;25:1327–1331. doi: 10.1038/sj.ijo.0801723.
    1. Sattar N, McConnachie A, O'Reilly D, Upton MN, Greer IA, Davey Smith G, Watt G. Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN Family Study. Arterioscler Thromb Vasc Biol. 2004;24:583–587. doi: 10.1161/01.ATV.0000118277.41584.63.
    1. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun. 2005;20:498–504. doi: 10.1016/j.bbi.2005.10.003.
    1. Onat A, Sansoy V, B BY, Keles I, Uysal O, Hergenc G. C-reactive protein and coronary heart disease in western Turkey. Am J Cardiol 2001. 2001;88:601–607. doi: 10.1016/S0002-9149(01)01799-4.
    1. Bo S, Gentile L, Ciccone G, Baldi C, Benini L, Dusio F, Lucia C, Forastiere G, Nuti C, Cassader M, Franco Pagano G. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev. 2005;21:515–524. doi: 10.1002/dmrr.561.
    1. Danesh J, Muir J, Wong Y, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J. 1999;20:954–959. doi: 10.1053/euhj.1998.1309.
    1. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Commun H. 2003;57:730–733. doi: 10.1136/jech.57.9.730.
    1. Kivimaki M, Lawlor DA, Juonala M, Smith GD, Elovainio M, Keltikangas-Jarvinen L, Vahtera J, Viikari JS, Raitakari OT. Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study. Arterioscler Thromb Vasc Biol. 2005;25:2197–2202. doi: 10.1161/01.ATV.0000183729.91449.6e.
    1. Loucks EB, Sullivan LM, Hayes LJ, D'Agostino RB, Sr., Larson MG, Vasan RS, Benjamin EJ, Berkman LF. Association of Educational Level with Inflammatory Markers in the Framingham Offspring Study. Am J Epidemiol. 2006;163:622–628. doi: 10.1093/aje/kwj076.
    1. McDade TW, Hawkley LC, Cacioppo JT. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom Med. 2006;68:376–381. doi: 10.1097/01.psy.0000221371.43607.64.
    1. Panagiotakos DB, Pitsavos C, Manios Y, Polychronopoulos E, Chrysohoou CA, Stefanadis C. Socio-economic status in relation to risk factors associated with cardiovascular disease, in healthy individuals from the ATTICA study. Eur J Cardiovasc Prev Rehabil. 2005;12:68–74. doi: 10.1097/00149831-200502000-00011.
    1. Panagiotakos D, Pitsavos C, Chrysohoou C, Skoumas J, Toutouza M, Belegrinos D, Toutouzas P, Stefanadis C. The association between educational status and risk factors related to cardiovascular disease in healthy individuals: The ATTICA study. Ann Epidemiol. 2004;14:188–194. doi: 10.1016/S1047-2797(03)00117-0.
    1. Rathmann W, Haastert B, Giani G, Koenig W, Imhof A, Herder C, Holle R, Mielck A. Is inflammation a causal chain between low socioeconomic status and type 2 diabetes? Results from the KORA Survey 2000. Eur J Epidemiol. 2006;21:55–60. doi: 10.1007/s10654-005-5085-6.
    1. St J O'Reilly D, Upton MN, Caslake MJ, Robertson M, Norrie J, McConnachie A, Watt GCM, Packard CJ, on behalf of the Midspan and Woscops study groups Plasma C reactive protein concentration indicates a direct relation between systemic inflammation and social deprivation. Heart. 2006;92:533–535. doi: 10.1136/hrt.2005.063081.
    1. Ford ES, Giles WH, Mokdad AH, Myers GL. Distribution and Correlates of C-Reactive Protein Concentrations among Adult US Women. Clin Chem. 2004;50:574–581. doi: 10.1373/clinchem.2003.027359.
    1. Ford ES, Giles WH, Myers GL, Mannino DM. Population Distribution of High-Sensitivity C-reactive Protein among US Men: Findings from National Health and Nutrition Examination Survey 1999-2000. Clin Chem. 2003;49:686–690. doi: 10.1373/49.4.686.
    1. Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, Elwood PC. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 2000;21:1584–1590. doi: 10.1053/euhj.1999.1982.
    1. Williams MJ, Williams SM, Milne BJ, Hancox RJ, Poulton R. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obes Relat Metab Disord. 2004;28:998–1003. doi: 10.1038/sj.ijo.0802713.
    1. Wong ND, Pio J, Valencia R. Distribution of C-Reactive Protein and Its Relation to Risk Factors and Coronary Heart Disease Risk Estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol. 2001;4:109–114. doi: 10.1111/j.1520-037X.2001.00570.x.
    1. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino Jr RB, Herrington DM. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J. 2006;152:593–598. doi: 10.1016/j.ahj.2006.02.015.
    1. Matthews KA, Sowers MF, Derby CA, Stein E, Miracle-McMahill H, Crawford SL, Pasternak RC. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN) Am Heart J. 2005;149:1066. doi: 10.1016/j.ahj.2004.08.027.
    1. Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, Lonn E, Teo K, McQueen M, Yusuf S. C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population. Arterioscler Thromb Vasc Biol. 2004;24:1509–1515. doi: 10.1161/01.ATV.0000135845.95890.4e.
    1. Wener MH, Daum PR, McQuillan GM. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol. 2000;27:2351–2359.
    1. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, Pepys MB, Kooner JS. C-Reactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites. Circulation. 2001;104:145–150.
    1. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians Jr FH, Grundy SM, de Lemos JA. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005;46:464–469. doi: 10.1016/j.jacc.2005.04.051.
    1. Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J. Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. Int J Epidemiol. 2005;34:327–334. doi: 10.1093/ije/dyi007.
    1. Gillman MW. Epidemiological challenges in studying the fetal origins of adult chronic disease. Int J Epidemiol. 2002;31:294–299. doi: 10.1093/ije/31.2.294.
    1. Singh-Manoux A, Ferrie JE, Chandola T, Marmot M. Socioeconomic trajectories across the life course and health outcomes in midlife: evidence for the accumulation hypothesis? Int J Epidemiol. 2004;33:1072–1079. doi: 10.1093/ije/dyh224.
    1. Davey Smith G, Hart C, Blane D, Hole D. Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study. BMJ. 1998;316:1631–1635.
    1. Godfrey K, Barker DJP. Fetal programming and adult health. Public Health Nutrition. 2001;4:611–624.
    1. Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease-the hypothesis revisited. BMJ. 1999;319:245–249.
    1. Milyo J, Mellor JM. On the Importance of Age-Adjustment Methods in Ecological Studies of Social Determinants of Mortality. Health Serv Res. 2003;38:1781–1790. doi: 10.1111/j.1475-6773.2003.00202.x.
    1. Freeman H. Race, Poverty, and Cancer. J Natl Cancer Inst. 1991;83:526–527. doi: 10.1093/jnci/83.8.526.
    1. US Census Bureau Historical poverty tables
    1. Joseph Rowntree Foundation Ethnic groups and low income distribution
    1. Lynch J, Davey Smith G, Harper S, Hillemeier M, Ross N, Kaplan GA, Wolfson M. Is income inequality a determinant of population health? Part I. A systematic review. The Millbank Quarterly. 2004;82:5–99. doi: 10.1111/j.0887-378X.2004.00302.x.
    1. Krieger N. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiol. 2001;30:668–677. doi: 10.1093/ije/30.4.668.
    1. Wilkinson RG, Marmot MG. Social Determinants of Health. 2. New York , Oxford University Press; 2006.
    1. Blakely T, Hales S, Kieft C, Wilson N, Woodward A. The global distribution of risk factors by poverty level. Bull World Health Organ. 2005;83:118–126.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner